Use of repurposed and adjuvant drugs in hospital patients with COVID-19: multinational network cohort study

Documenti analoghi

• Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
  di: Burn, E, et al.
  Pubblicazione: (2020)
• Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
  di: Lane, JCE, et al.
  Pubblicazione: (2020)
• Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
  di: Lane, JCE, et al.
  Pubblicazione: (2020)
• COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
  di: Tan, EH, et al.
  Pubblicazione: (2021)
• Partial knee replacement is associated with a lower risk of venous thromboembolism and opioid use than total knee replacement but increased risk of long-term revision: a multinational, multi-database, propensity score-matched, cohort analysis including over 280,000 patients
  di: Prieto-Alhambra, D, et al.
  Pubblicazione: (2019)